why choose us

First received: April 30, 2023

Clinical Trial: BEAT AF - Braking Ectopic Atrial Trends In Atrial Fibrillation

Study Status: Completed

Recruit Status: RECRUITING

Condition: Paroxysmal Atrial Fibrillation

Study Type: INTERVENTIONAL


Official Title: A Multi Center Randomized, Double Blinded, Sham Controlled, Clinical Study Aimed to Determine the Efficacy of CardiaCare™ RR2 Home-care Neuromodulation System in Reducing Atrial Fibrillation Burden an

Brief Summary: Paroxysmal AF subjects with a documented ECG event of AF will be recruited to the study To assess the efficacy of CardiaCare™ RR2 wearable home-care neuromodulation system in reducing AF burden and symptoms in Paroxysmal AF patients

Read more